Ardelyx announces publication of a review article demonstrating rapid and meaningful symptom relief with tenapanor in irritable bowel syndrome with constipation
Ardelyx Inc. announced the publication of data from its IBS-C clinical development program, “Tenapanor is associated with earlier and sustained symptom relief in IBS-C: a post hoc analysis”… read more.
